Below are the most recent publications written about "Mutation" by people in Profiles.
-
Connelly SV, Muller JG, Ali M, Ngasala BE, Hassan W, Mohamed B, Thwai KL, Sadler JM, Marglous J, Fola AA, Zacharia A, Shija SJ, Mohammed S, C Msolo D, Said H, Peter EE, Odas M, Rutha IJ, Nwange M, Naire K, Ruybal-Pes?ntez S, Verity R, Crudale R, Goel V, Choloi BB, Bj?rkman A, Bailey JA, Lin JT, Juliano JJ. Artemisinin Partial Resistance Mutations in Zanzibar and Tanzania Suggest Regional Spread and African Origins, 2023. J Infect Dis. 2026 Feb 18; 233(2):e491-e495.
-
Yuan R, Xie Y, Miron PM, Higgins AW, Hutchinson L, Cerny J, Patel SA. Clinico-genomic characterization of RAS-mutant acute myeloid leukemia. Ann Hematol. 2026 Feb 09; 105(3):99.
-
Ertekin A, Noronha ST, Darko C, Massi F, Ryder SP. A conserved triple arginine motif in OMA-1 is required for RNA-binding activity and embryo viability. RNA. 2025 Oct 16; 31(11):1575-1588.
-
Martin AC, Sadler JM, Simkin A, Musonda M, Katowa B, Matoba J, Schue J, Simulundu E, Bailey JA, Moss WJ, Juliano JJ, Fola AA. Emergence and Rising Prevalence of Artemisinin Partial Resistance Marker Kelch13 P441L in a Low Malaria Transmission Setting in Southern Zambia. J Infect Dis. 2025 Oct 15; 232(4):918-922.
-
Fuster-Matanzo A, Pic?-Peris A, Bellv?s-Bataller F, Jimenez-Pastor A, Weiss GJ, Mart?-Bonmat? L, L?zaro S?nchez A, Bazaga D, Banna GL, Addeo A, Camps C, Seijo LM, Alberich-Bayarri ?. Prediction of oncogene mutation status in non-small cell lung cancer: a systematic review and meta-analysis with a special focus on artificial intelligence-based methods. Eur Radiol. 2026 Mar; 36(3):2157-2185.
-
Jeffries AM, Yu T, Ziegenfuss JS, Tolles AK, Baer CE, Sotelo CB, Kim Y, Weng Z, Lodato MA. Single-cell transcriptomic and genomic changes in the ageing human brain. Nature. 2025 Oct; 646(8085):657-666.
-
Diamond B, Chahar D, Jain MD, Poos AM, Durante MA, Ziccheddu B, Kaddoura M, Papadimitriou M, Maclachlan KH, Jelinek T, Davies FE, Figura NB, Morgan GJ, Mai EK, Weisel K, Fenk R, Raab MS, Usmani S, Landgren O, Locke FL, Goldschmidt H, Schatz JH, Weinhold N, Maura F. Mutagenic Impact and Evolutionary Influence of Chemoradiotherapy in Hematologic Malignancies. Blood Cancer Discov. 2025 Sep 03; 6(5):450-463.
-
Bamidele N, Pires-Ferreira D, Zheng C, Destefano A, Cheng H, Tang Q, Cao Y, Xie J, Gao G, Gruntman A, Sontheimer E, Flotte TR, Xue W. A compact base editor rescues AATD-associated liver and lung disease in mouse models. Mol Ther. 2025 Nov 05; 33(11):5817-5828.
-
Maura F, Kaddoura M, Poos AM, Baughn LB, Ziccheddu B, B?rtsch MA, Cirrincione A, Maclachlan K, Chojnacka M, Diamond B, Papadimitriou M, Blaney P, John L, Reichert P, Huhn S, Gagler D, Zhang Y, Dogan A, Lesokhin AM, Davies F, Goldschmidt H, Fenk R, Weisel KC, Mai EK, Korde N, Morgan GJ, Rajkumar SV, Kumar S, Usmani S, Landgren O, Raab MS, Weinhold N. Temporal genomic dynamics shape clinical trajectory in multiple myeloma. Nat Genet. 2025 Sep; 57(9):2203-2214.
-
Zhu W, Zhang Y, Sahay H, Wasserman H, Afek A, Williams J, Shaltz S, Johnson C, Pinheiro K, MacAlpine DM, Weninger KR, Erie DA, Jinks-Robertson S, Gord?n R. DNA mutagenesis driven by transcription factor competition with mismatch repair. Cell. 2025 Oct 02; 188(20):5735-5747.e15.